Bottom Line Research on BPC-157 as a regenerative peptides is promising in animals, but the human trial data is low quality, extremely sparse and in many cases completely absent
Food and Nutrition Board, Institute of Medicine
Some people believe it can help brighten skin and improve skin health
Tonneijck, L
Injection-Based Administration Subcutaneous injections: All GLP-1 RAs are administered via subcutaneous injection Prefilled pens: Most common delivery system, allows for self-administration Auto-injectors: Simplify the process for patients with dexterity issues Multi-dose pens: Require dose dialing and needle attachment Dosing frequency: Daily: Liraglutide (Saxenda, Victoza), some formulations of exenatide (Byetta) Weekly: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide extended-release (Bydureon) Titration schedules: Most FDA-approved GLP-1 RAs require gradual dose escalation to minimize gastrointestinal side effects
Taurine also participates in cell volume regulation, membrane stability and antioxidant and inflammatory signaling